Alector, Inc. Operating Cash Flow
Alector, Inc. (ALEC) reported Operating Cash Flow of -$84.03 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-06
- Alector, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$34.22M.
- Alector, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$49.81M.
- Alector, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was -$41.69M.
- Alector, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was -$32.51M.
- Alector, Inc. net cash provided by (used in) operating activities for fiscal 2025 was -$184.03M.
- Alector, Inc. net cash provided by (used in) operating activities for fiscal 2024 was -$229.91M.
- Alector, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$184.16M.
- Alector, Inc. net cash provided by (used in) operating activities for fiscal 2022 was -$20.33M, a 106.81% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$34.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$84.03M 10-Q · filed 2026-08-06 | -$125.72M derived: sum of 3 quarters · filed 2026-08-06 | -$158.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$49.81M 10-Q · filed 2026-05-07 | -$91.50M derived: sum of 2 quarters · filed 2026-05-07 | -$124.02M derived: sum of 3 quarters · filed 2026-05-07 | -$173.06M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$41.69M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$74.20M derived: sum of 2 quarters · filed 2026-02-25 | -$123.25M derived: sum of 3 quarters · filed 2026-08-06 | -$184.03M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$32.51M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$81.56M derived: sum of 2 quarters · filed 2026-08-06 | -$142.34M 10-Q · filed 2025-11-06 | -$197.37M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$49.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$109.83M 10-Q · filed 2026-08-06 | -$164.86M derived: sum of 3 quarters · filed 2026-08-06 | -$215.59M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$60.78M 10-Q · filed 2026-05-07 | -$115.81M derived: sum of 2 quarters · filed 2026-05-07 | -$166.54M derived: sum of 3 quarters · filed 2026-05-07 | -$229.34M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$55.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$105.76M derived: sum of 2 quarters · filed 2026-02-25 | -$168.56M derived: sum of 3 quarters · filed 2026-02-25 | -$229.91M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$50.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$113.53M derived: sum of 2 quarters · filed 2025-11-06 | -$174.88M 10-Q · filed 2025-11-06 | -$220.95M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | -$62.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$124.14M 10-Q · filed 2025-08-07 | -$170.21M derived: sum of 3 quarters · filed 2025-08-07 | -$216.75M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | -$61.35M 10-Q · filed 2025-05-08 | -$107.42M derived: sum of 2 quarters · filed 2025-05-08 | -$153.96M derived: sum of 3 quarters · filed 2025-05-08 | -$196.96M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$46.07M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$92.61M derived: sum of 2 quarters · filed 2025-02-26 | -$135.61M derived: sum of 3 quarters · filed 2025-02-26 | -$184.16M 10-K · filed 2025-02-26 |
| 2023-09-30 | -$46.54M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | -$89.54M derived: sum of 2 quarters · filed 2024-11-06 | -$138.09M 10-Q · filed 2024-11-06 | -$187.02M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | -$43.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$91.55M 10-Q · filed 2024-08-07 | -$140.48M derived: sum of 3 quarters · filed 2025-02-26 | -$189.53M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | -$48.55M 10-Q · filed 2024-05-08 | -$97.47M derived: sum of 2 quarters · filed 2025-02-26 | -$146.53M derived: sum of 3 quarters · filed 2025-02-26 | -$203.97M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$48.92M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$97.98M derived: sum of 2 quarters · filed 2025-02-26 | -$155.42M derived: sum of 3 quarters · filed 2025-02-26 | -$20.33M 10-K · filed 2025-02-26 |
| 2022-09-30 | -$49.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | -$106.50M derived: sum of 2 quarters · filed 2023-11-07 | $28.60M 10-Q · filed 2023-11-07 | -$20.67M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | -$57.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $77.65M 10-Q · filed 2023-08-03 | $28.38M derived: sum of 3 quarters · filed 2024-02-27 | $473.44M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $135.09M 10-Q · filed 2023-05-04 | $85.83M derived: sum of 2 quarters · filed 2024-02-27 | $530.88M derived: sum of 3 quarters · filed 2024-02-27 | $486.33M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | -$49.27M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $395.79M derived: sum of 2 quarters · filed 2024-02-27 | $351.24M derived: sum of 3 quarters · filed 2024-02-27 | $298.55M 10-K · filed 2024-02-27 |
| 2021-09-30 | $445.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $400.51M derived: sum of 2 quarters · filed 2022-11-08 | $347.82M 10-Q · filed 2022-11-08 | $300.16M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$44.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | -$97.24M 10-Q · filed 2022-08-04 | -$144.89M derived: sum of 3 quarters · filed 2023-02-28 | -$185.72M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$52.69M 10-Q · filed 2022-05-05 | -$100.35M derived: sum of 2 quarters · filed 2023-02-28 | -$141.17M derived: sum of 3 quarters · filed 2023-02-28 | -$187.11M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$47.66M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$88.48M derived: sum of 2 quarters · filed 2023-02-28 | -$134.42M derived: sum of 3 quarters · filed 2023-02-28 | -$166.73M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$40.82M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$86.76M derived: sum of 2 quarters · filed 2021-11-04 | -$119.08M 10-Q · filed 2021-11-04 | -$147.90M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | -$45.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | -$78.25M 10-Q · filed 2021-08-03 | -$107.08M derived: sum of 3 quarters · filed 2022-02-24 | -$135.94M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | -$32.31M 10-Q · filed 2021-05-05 | -$61.14M derived: sum of 2 quarters · filed 2022-02-24 | -$90.00M derived: sum of 3 quarters · filed 2022-02-24 | -$108.06M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | -$28.83M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$57.69M derived: sum of 2 quarters · filed 2022-02-24 | -$75.74M derived: sum of 3 quarters · filed 2022-02-24 | -$99.31M 10-K · filed 2022-02-24 |
| 2019-09-30 | -$28.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | -$46.91M derived: sum of 2 quarters · filed 2020-11-10 | -$70.48M 10-Q · filed 2020-11-10 | -$88.14M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | -$18.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-11 | -$41.62M 10-Q · filed 2020-08-11 | -$59.27M derived: sum of 3 quarters · filed 2021-02-25 | -$81.63M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | -$23.57M 10-Q · filed 2020-05-13 | -$41.22M derived: sum of 2 quarters · filed 2021-02-25 | -$63.58M derived: sum of 3 quarters · filed 2021-02-25 | -$80.63M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | -$17.65M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$40.01M derived: sum of 2 quarters · filed 2021-02-25 | -$57.06M derived: sum of 3 quarters · filed 2021-02-25 | $127.46M 10-K · filed 2021-02-25 |
| 2018-09-30 | -$22.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$39.41M derived: sum of 2 quarters · filed 2019-11-12 | $145.12M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | -$17.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-12 | $167.48M 10-Q · filed 2019-08-12 | ||
| 2018-03-31 | $184.53M 10-Q · filed 2019-05-13 | |||
| 2017-12-31 | -$17.77M 10-K · filed 2020-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |